SUMMARY This paper urges the benefits of applying more widely a method for pathology laboratory costing originally devised for a clinical chemistry department, and illustrates these with examples drawn from costing studies in three clinical laboratories.
In 1981 Broughton and Hogan published a method for costing a clinical chemistry department' which is simpler, more logical and more comprehensible than previously published methods.24 A novel feature of these authors' approach was to separate costs into those involved in providing the basic facility-that is, an appropriately staffed and equipped laboratory competent to fulfil the requests made to it-and the actual direct costs of performing individual test procedures, and to apply these figures separately to answer different types of management question.
So far, there has been no stampede to apply this method in other clinical laboratories, despite the current financial restrictions and the concern about the cost of "high technology" diagnostic tests.5 Reluctance to embark on costing studies stems from a mistaken belief that the amount of effort necessary for reliable costing is incommensurate with the possible benefits.
This paper outlines the principles of the Broughton and Hogan method and explains which elements of the procedure can be used to answer costing questions asked by pathologists, administrators or clinicians. The usefulness of the method is illustrated by *Based on research commissioned by the Department of Health and Social Security at the Wolfson Research Laboratories. The views expressed should not be taken as official Departmental policy on laboratory costing. Accepted for publication 5 April 1983 ©) Crown copynght 1983. its application to three clinical chemistry laboratories, but there is every reason to believe that it can be applied without change in other pathology disciplines.
Principles of the costing method of Broughton and Hogan'
Throughout pathology the basic unit of work is the request, representing a clinical question, which may require one or more tests or test groups to be performed. Before devising any costing procedure it is most important to define exactly what is meant by "cost per request" and "cost per test" and why each value is needed. Otherwise, management and planning will be bedevilled by uncertainty and confusion.
A basic requirement for a satisfactory laboratory costing method is the attribution of all items of expenditure to one or other aspect of the service provided. This allows a balance sheet in which the sum of the cost of all individual items equals the known expenditure. Isolated costing of one area of work or of single tests is usually unsatisfactory because the results cannot be cross-checked against the total expenditure.
In order to apportion expenditure between different types of work, direct costs must be identifiedthat is, those costs which are necessarily and exclusively incurred in performing a specified test at a particular time. ' Table 4 shows examples of direct costs of some tests in one laboratory, as well as the indirect cost per request in that laboratory, analysed into consumable, labour and capital components. The cost of each test type may be expressed either as the average direct cost per test performed, which is conventional, or as the total annual direct expenditure on each type of test, which is of greater use to the laboratory manager.
In addition to the average direct cost per test the direct costs of the same tests performed at different times, for example as part of a batch or as an emergency (Table 5) , within and out of normal working hours, can be obtained. Given that the number of staff employed cannot be changed in the short term, the total labour costs will be unchanged. Only expenditure on direct consumables need therefore be considered. This is made up of fixed costs that are independent of workload, and variable or workload-dependent costs (Table 6) . With a flame photometer, the variable costs are directly related to the running time of the instrument, but for the ISE analyser they depend on the workload, batch size and time between batches. Furthermore, the ISE analyser incurs direct costs even when no specimens are analysed. Consequently the relation between costs and workload is not a simple one. The calculations in Table 6 , which are given for illustrative purposes only, are based on the actual workload of an emergency laboratory analysing serum and urine specimens by day and night. They show that use of the ISE analyser to deal with this workload distribution would increase the annual expenditure on consumables by £3116. Expressing the data in this form also allows calcula- The conclusion is that the revenue consequences of purchasing the ISE analyser would be considerable, and much more important economically than the capital outlay (less than £600 per annum, assuming a 1 0-year lifespan). This is largely due to the cost of reagents which can only be obtained from the instrument manufacturer. Furthermore, because of the high cost of the urine diluent (£0-67 per test in this example), the extent of the revenue consequences will depend to a large extent on Data given elsewhere' and in Tables 5 and 7 indicate that the direct cost per test, of both labour and consumables, decreases as workload increases in a manner which depends on the type of test. Expenditure on consumables can often be confidently predicted by listing them in detail as in Table 6 , but for some tests this is more difficult. With assay kits, for example, the amount of reagent prepared should ideally match the daily workload. This means that the analysis of the 21st specimen, when the reagent vial is only sufficient for 20, will produce a stepwise increase in expenditure and cost per test. On the other hand, assay of only 10 specimens will result in wastage and also increase the cost per test. In practice, the daily workload varies and the average must be calculated over a representative period.
So long as a test remains in the laboratory repertoire, reagents must be purchased and staff be available to do it. A supposedly effective method of achieving savings is to delete unwanted or uninformative tests from the repertoire altogether, but unless the number of staff is reduced, there will be no net saving in labour costs because the direct labour saved will either be added to the reservoir of indirect labour or deployed on a different test. As a result, costs will be redistributed but expenditure will not change. Savings in expenditure would then be less than anticipated from a simplistic prediction Similar considerations apply in assessing the extra cost of tests performed out of hours. With the present system of payment used in the UK for out-ofhours work, these costs, which are mainly for labour, are directly related to workload, and immediate cash savings could be made by reducing the number of out-of-hours tests-but only if this had no adverse cost consequences in the clinical sphere.
Investigation of patients before admission to hospital, and the rapid provision of assays such as serum drug levels for outpatients, can often be made at little or no extra expense for the laboratory, but may save clinical costs. The complexity of these nonlaboratory costs, and the difficulty of measuring them, constitute an unmet challenge in making a complete assessment of the overall cost consequences of performing a test at once or after a delay.
Similar considerations arise in assessing the cost/ benefit of performing a fixed battery of tests whenever any one of them is requested. The cost of a biochemical profile is remarkably small when performed on a modern multichannel automated analyser (Table 7) , and indirect costs are reduced because of the simplification of specimen separation, work organisation and reporting. However, the present popularity of profiling amongst laboratory workers overlooks two important factors.
First, although the use of multichannel analysers reduces the apparent cost of each test, this is of no value if the test results are irrelevant or even misleading for individual patients. There is at present no evidence that the faster turnround of tests achieved by profiling produces any significant clinical savings. Moreover, any additional investigation induced by unrequested, unexpected results will entail additional expenditure, often without clinical benefit. On the other hand, to do such tests only when requested may result in delays, and will increase the indirect costs of specimen separation, sorting, etc. Consequently the full cost implications of including or excluding an analyte in a profile are far from straightforward. Equipment for automated discretionary testing is now becoming available, and it will be important to assess how this will affect laboratory and clinical costs.
A second consequence of the use of multichannel analysers is that, although each test or profile is inexpensive, profiles are done in large numbers, so that the annual expenditure on them is large. This perhaps provides justification for the widely held belief that automatic analysers are expensive whereas, on a cost per test basis, they are not. The availability of such equipment, able to do large numbers of cheap tests, stimulates demand, so that the total expenditure on them rises until it consumes a major part of the laboratory's budget.
In assessing the cost-effectiveness of laboratories, and the effect of changes in practice and organisation, it may be useful to compare data from different laboratories (Table 3) . To the administrator, using the only data available to him, the comparison figure would be the total revenue expenditure divided by the number of requests-that is, the average revenue cost per request: £3*99 for laboratory A and £6.31 for laboratory B. The 60% difference is explainable on the grounds that laboratory B is an independent clinical chemistry department, with medical staff, in a teaching hospital, whereas laboratory A is located in a multidisciplinary department in a District General Hospital and has no medical staff. However, this explanation takes no account of differences in actual investigations performed in the two laboratories, and a more detailed analysis is more revealing.
The average direct cost per request (a measure not available without detailed cost analysis) in the two laboratories again differs, though in lesser degree (43%): £1*40 for A and £2-01 for B. However, greater differences emerge when the costs of individual tests are compared (Table 7) . For many analytes (blood alcohol, faecal fat, acid phosphatase, calcium), the cost per test is, predictably, lower in the laboratory where it is done in larger numbers, but there are additional marked differences between A and B which are probably method-related. Although a few generalisations about the cost per test can be made from these data, the figures could by no stretch of the imagination be used as a basis for a joint, let alone a national, price list.
There are interesting differences between 1033 What answer should the head of a laboratory give to the clinician or medical student who asks "What is the cost of Test X?" The question is deceptively simple, but several equally valid answers are possible. In the first place, it will be clear from the foregoing that the answer will be different for each laboratory, and that a guess which ignores the less obvious indirect costs will be misleading.
The simplest general answer is to state, for that laboratory, the average total cost per request for that test, ie the direct costs of consumables, labour and capital, plus the "handling charge" for indirect costs. Thus for laboratory B (Table 4 ) the average cost of a request for serum digoxin assay is £10*24 (total direct) plus £4*80 (indirect), making a total of 1034 £14*04. Although the figure will be higher for an out-of-hours request, the average figure serves as a general guide in answering the clinician's question. It represents the without-profit "marketplace" cost, which should not be too dissimilar from the price charged by commercial laboratories. The element of profit built into the commercial price is approximately matched by the cost of the research, advisory and consultative functions provided by the hospital laboratory.
The main reason for higher laboratory costs over the past few years is the increased number of requests made by clinicians.578 Attempts to modify clinicians' requesting patterns have not met with great success9-" and whether clinicians would be greatly influenced by knowing the cost of a test-for example, if this were printed on the laboratory report-is at the least dubious.' -'3 Tests which appear relatively cheap on a unit basis may easily lead to additional demands, and if these demands are readily met with high-throughput automated equipment, total expenditure will increase. For this reason the total cost for a particular request is the most appropriate figure to give to the interested clinician, not the "direct cost per test" which is often demanded by planners and quoted by manufacturers of equipment and reagents.
Estimates of the potential savings which would result from discontinuing unnecessary investigations'4 '5 are often equated with the average cost per request (which is the only figure available). This is highly misleading since in most cases the only real saving in the short term in discontinuing a test is in direct consumable costs, which are usually a small proportion of total costs: that is, marginal costs are equal to marginal savings.
On the other hand, the cost of setting up a new assay which is not in the laboratory's repertoire is much greater, since additional equipment may be needed or extra staff employed.
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